Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Markers of instability in high-risk carotid plaques are reduced by statins.

Kunte H, Amberger N, Busch MA, Rückert RI, Meiners S, Harms L.

J Vasc Surg. 2008 Mar;47(3):513-22. doi: 10.1016/j.jvs.2007.11.045.

2.
3.

Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability.

Sigala F, Kotsinas A, Savari P, Filis K, Markantonis S, Iliodromitis EK, Gorgoulis VG, Andreadou I.

J Vasc Surg. 2010 Sep;52(3):704-13. doi: 10.1016/j.jvs.2010.03.047. Epub 2010 Jun 22.

4.

Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy.

Hellings WE, Pasterkamp G, Verhoeven BA, De Kleijn DP, De Vries JP, Seldenrijk KA, van den Broek T, Moll FL.

J Vasc Surg. 2007 Feb;45(2):289-96; discussion 296-7.

6.

Leptin receptor is elevated in carotid plaques from neurologically symptomatic patients and positively correlated with augmented macrophage density.

Schneiderman J, Simon AJ, Schroeter MR, Flugelman MY, Konstantinides S, Schaefer K.

J Vasc Surg. 2008 Nov;48(5):1146-55. doi: 10.1016/j.jvs.2008.06.054. Epub 2008 Sep 30.

7.

Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation.

Shaalan WE, Cheng H, Gewertz B, McKinsey JF, Schwartz LB, Katz D, Cao D, Desai T, Glagov S, Bassiouny HS.

J Vasc Surg. 2004 Aug;40(2):262-9.

8.

Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins.

Katsargyris A, Klonaris C, Tsiodras S, Bastounis E, Giannopoulos A, Theocharis S.

Vascular. 2011 Dec;19(6):320-6. doi: 10.1258/vasc.2011.oa0306. Epub 2011 Sep 8.

PMID:
21903856
9.

Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.

van Oostrom O, Velema E, Schoneveld AH, de Vries JP, de Bruin P, Seldenrijk CA, de Kleijn DP, Busser E, Moll FL, Verheijen JH, Virmani R, Pasterkamp G.

Cardiovasc Pathol. 2005 May-Jun;14(3):126-34.

PMID:
15914297
10.

Association between 5-lipoxygenase expression and plaque instability in humans.

Cipollone F, Mezzetti A, Fazia ML, Cuccurullo C, Iezzi A, Ucchino S, Spigonardo F, Bucci M, Cuccurullo F, Prescott SM, Stafforini DM.

Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1665-70. Epub 2005 Jun 2.

11.

Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.

Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Piagnerelli R, Cavallaro A.

Eur J Vasc Endovasc Surg. 2004 Jul;28(1):89-97.

12.

Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study.

Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM.

Circulation. 2006 May 16;113(19):2320-8. Epub 2006 May 1.

13.

MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.

Sapienza P, Borrelli V, di Marzo L, Cavallaro A.

Eur J Vasc Endovasc Surg. 2009 May;37(5):525-30. doi: 10.1016/j.ejvs.2009.01.012. Epub 2009 Mar 17.

14.

Carotid plaque composition in chronic kidney disease: a retrospective analysis of patients undergoing carotid endarterectomy.

Pelisek J, Assadian A, Sarkar O, Eckstein HH, Frank H.

Eur J Vasc Endovasc Surg. 2010 Jan;39(1):11-6. doi: 10.1016/j.ejvs.2009.09.024. Epub 2009 Nov 10.

15.

Atherosclerotic plaque rupture in symptomatic carotid artery stenosis.

Carr S, Farb A, Pearce WH, Virmani R, Yao JS.

J Vasc Surg. 1996 May;23(5):755-65; discussion 765-6.

16.

Hydrocortisone supresses inflammatory activity of metalloproteinase-8 in carotid plaque.

Gabriel SA, Antonangelo L, Capelozzi VL, Beteli CB, Camargo Júnior Od, Aquino JL, Caffaro RA.

Rev Bras Cir Cardiovasc. 2015 Jul-Sep;30(3):295-303. doi: 10.5935/1678-9741.20150034.

17.

Preoperative statin and diuretic use influence the presentation of patients undergoing carotid endarterectomy: results of a large single-institution case-control study.

Brooke BS, McGirt MJ, Woodworth GF, Chang DC, Roseborough GS, Freischlag JA, Perler BA.

J Vasc Surg. 2007 Feb;45(2):298-303.

18.

Increased vascularization of shoulder regions of carotid atherosclerotic plaques from patients with diabetes.

Olson FJ, Strömberg S, Hjelmgren O, Kjelldahl J, Fagerberg B, Bergström GM.

J Vasc Surg. 2011 Nov;54(5):1324-1331.e5. doi: 10.1016/j.jvs.2011.04.061. Epub 2011 Jul 20.

19.

Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study.

Krupinski J, Turu MM, Font MA, Catena E, Slevin M, Morchon S, Rubio F, Badimon L, Martínez-González J.

Cerebrovasc Dis. 2008;25(1-2):32-9. Epub 2007 Nov 22.

PMID:
18033956
20.

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.

Cipollone F, Fazia M, Iezzi A, Pini B, Cuccurullo C, Zucchelli M, de Cesare D, Ucchino S, Spigonardo F, De Luca M, Muraro R, Bei R, Bucci M, Cuccurullo F, Mezzetti A.

Circulation. 2004 Mar 30;109(12):1482-8. Epub 2004 Mar 22.

Supplemental Content

Support Center